Related Experiment Video
Updated: Aug 30, 2025

Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
The Risk of Emerging Resistance to Trimethoprim/Sulfamethoxazole in Staphylococcus aureus
Takumi Sato1, Ryota Ito1, Masato Kawamura1
1Division of Clinical Infectious Diseases & Chemotherapy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Objective:
Due to the spread of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), the demand for trimethoprim/sulfamethoxazole (SXT) is increasing in the world. It is not clear whether the resistant strain emerges by overuse of SXT. We investigated here the emergent risk of the SXT-resistant mutant in S. aureus by an in vitro SXT exposure experiment.
Methods:
A total of 40 S. aureus clinical isolates (20 MSSA and 20 MRSA isolates) were exposed to sub-MIC of SXT for consecutive days, and MIC of SXT was determined every day. In addition, the dfrB DNA sequencing was performed to detect the mutation in the SXT-resistant strain.
Results:
The SXT-resistant strain began to emerge on the eighth day and accounted for 45% (18/40 clinical isolates) after 14 days. Moreover, one half of these resistant strains showed F98Y mutation in DfrB to retain SXT-resistance without selective pressure.
Conclusion:
The emergent risk was SXT exposure of 14 days or more.
Insights
The study found that prolonged exposure to trimethoprim/sulfamethoxazole (SXT) increases the risk of developing SXT-resistant Staphylococcus aureus strains. This emergence of resistant bacteria highlights the need for careful antibiotic use.
Area of Science:
- Microbiology
- Infectious Diseases
- Antimicrobial Resistance
Background:
- The increasing prevalence of community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA) drives global demand for trimethoprim/sulfamethoxazole (SXT).
- The potential for SXT overuse to drive the emergence of resistant strains remains unclear.
Purpose of the Study:
- To investigate the risk of trimethoprim/sulfamethoxazole (SXT)-resistant Staphylococcus aureus mutant emergence through in vitro SXT exposure.
- To analyze the genetic mutations associated with SXT resistance in Staphylococcus aureus.
Main Methods:
- Exposure of 40 clinical Staphylococcus aureus isolates (20 MSSA, 20 MRSA) to sub-inhibitory concentrations of SXT daily.
- Daily determination of SXT Minimum Inhibitory Concentration (MIC) and dfrB DNA sequencing to identify resistance mutations.
Main Results:
- SXT-resistant strains emerged by day 8 and reached 45% prevalence (18/40 isolates) after 14 days of exposure.
- Half of the resistant strains exhibited the F98Y mutation in the dfrB gene, conferring SXT resistance even without ongoing selective pressure.
Conclusions:
- Prolonged SXT exposure, specifically 14 days or more, significantly increases the risk of SXT-resistant Staphylococcus aureus emergence.
- The identified dfrB mutation suggests a mechanism for sustained resistance development in Staphylococcus aureus.
Related Concept Videos
Development of Antibiotic Resistance
Mismatch Repair
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Antibiotic Selection
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Urine Studies II: Urine Culture and Sensitivity Test

